Status:
COMPLETED
Epidural Morphine Following Vaginal Delivery
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborating Sponsors:
The Physicians' Services Incorporated Foundation
Conditions:
Pain
Eligibility:
FEMALE
16-50 years
Phase:
PHASE4
Brief Summary
The investigators believe that pain management following a vaginal delivery can be improved. Many women receive epidural medication during labor and delivery, and the investigators felt that using the...
Detailed Description
Vaginal deliveries comprise 80-85% of all deliveries. Although this is felt to be natural and safe, this route can be associated with significant perineal trauma and subsequent postpartum perineal pai...
Eligibility Criteria
Inclusion
- Healthy parturients (ASA 1 or 2) of \> 34 weeks gestational age who chose epidural analgesia for labor, and deliver vaginally.
Exclusion
- Women whose labor is terminated by cesarean delivery
- Parturients with known morphine allergy
- Parturients with narcotic addiction past / present
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2005
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT00803114
Start Date
March 1 2002
End Date
February 1 2005
Last Update
January 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5